Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl/+ osteogenesis imperfecta model.
about
Developments in rare bone diseases and mineral disorders.Splenomegaly, myeloid lineage expansion and increased osteoclastogenesis in osteogenesis imperfecta murine.Low dose of bisphosphonate enhances sclerostin antibody-induced trabecular bone mass gains in Brtl/+ osteogenesis imperfecta mouse model.
P2860
Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl/+ osteogenesis imperfecta model.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Single dose of bisphosphonate ...... osteogenesis imperfecta model.
@en
Single dose of bisphosphonate ...... osteogenesis imperfecta model.
@nl
type
label
Single dose of bisphosphonate ...... osteogenesis imperfecta model.
@en
Single dose of bisphosphonate ...... osteogenesis imperfecta model.
@nl
prefLabel
Single dose of bisphosphonate ...... osteogenesis imperfecta model.
@en
Single dose of bisphosphonate ...... osteogenesis imperfecta model.
@nl
P2093
P2860
P1433
P1476
Single dose of bisphosphonate ...... osteogenesis imperfecta model.
@en
P2093
Basma M Khoury
Benjamin P Sinder
Bethany Meyer
David K Barton
Ferrous S Ward
Joan C Marini
Joseph E Perosky
Kai Cortright
Kenneth M Kozloff
Michelle S Caird
P2860
P356
10.1016/J.BONE.2016.09.013
P577
2016-09-15T00:00:00Z